EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic fate and detectability of three novel fluoroprolintane psychostimulants: in vitro and in vivo characterization by hyphenated mass spectrometry

Lea Wagmann iD, Anica Herter, Michael B Dybek, Adeboye Adejare, Jason Wallach, Simon D Brandt, Markus R Meyer

Archives of Toxicology · 2026

DOI: 10.1007/s00204-026-04462-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, 2026. Verfasst von Lea Wagmann und 6 weiteren Autor:innen. Beteiligte Einrichtung: Experimental and Clinical Toxicology and Pharmacology, Center for Molecular Signaling (PZMS), PharmaScienceHub (PSH), Saarland University, Kirrberger…. Hauptthemen laut MEDLINE: Pyrrolidines, Central Nervous System Stimulants. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universität des Saarlandes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amphetamine-type stimulants (ATS) represent a major segment of the global drugs of abuse market. Prolintane (1-(1-phenylpentan-2-yl)pyrrolidine), a substituted phenylethylamine ATS, was historically utilized as medication for several therapeutic indications. This study aimed to investigate the metabolic fate and urinary detectability of the three novel derivatives 2-, 3-, and 4-fluoroprolintane, which were recently shown to act as monoamine reuptake inhibitors. Liquid chromatography (LC)-high-resolution (HR) tandem mass spectrometry (MS/MS) was used for tentative identification of metabolites in rat urines (collected over a 24 h period following oral administration of 2 mg/kg fluoroprolintane isomer, each) or incubations with pooled human liver S9 fraction (1 h and 6 h, 25 µM fluoroprolintane isomer, each). Isozyme mapping was performed using individual incubations with 11 human phase I monooxygenases. The same rat urines were used for detectability studies using standard urine screening approaches (SUSA) by gas chromatography (GC)-mass spectrometry (MS), LC-ion trap MS, and LC-HRMS/MS. The fluoroprolintanes were extensively metabolized, with a total of 79 metabolites identified. Hydroxylations and subsequent oxidations were primarily mediated by CYP1A2, CYP2B6, CYP2C19, and CYP2D6, while glucuronidation and O -methylation were observed as main follow-up phase II reactions. All three SUSA allowed detection, primarily via metabolites. However, the high degree of metabolic overlap will make isomer differentiation challenging. These findings contribute to a comprehensive risk assessment and provide critical reference data for clinical and forensic laboratories to identify these substances in biological specimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrrolidinesCentral Nervous System StimulantsAnimalsHumansTandem Mass SpectrometryMaleRatsGas Chromatography-Mass SpectrometryChromatography, LiquidRats, Sprague-DawleyLiquid Chromatography-Mass SpectrometryMicrosomes, LiverSubstance Abuse DetectionAdministration, Oral

Stichwörter der Autor:innen

LC-HRMS/MSMetabolismNew psychoactive substancesStimulantsToxicokineticsUrine screening

Substanzen

PyrrolidinesCentral Nervous System Stimulants

Autor:innen und Institutionen

  • Experimental and Clinical Toxicology and Pharmacology, Center for Molecular Signaling (PZMS), PharmaScienceHub (PSH), Saarland University, Kirrberger Str. / Geb. 48.5, 66421, Homburg, Germany. lea.wagmann@uks.eu.
  • Experimental and Clinical Toxicology and Pharmacology, Center for Molecular Signaling (PZMS), PharmaScienceHub (PSH), Saarland University, Kirrberger Str. / Geb. 48.5, 66421, Homburg, Germany.
  • Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, Saint Joseph's University, Philadelphia, USA.
  • Alexander Shulgin Research Institute, Lafayette, CA, USA.

ORCID-Profile: Lea Wagmann

Förderung

  • Universität des Saarlandes

Zitieren

APA

Wagmann, L., Herter, A., Dybek, M. B., Adejare, A., Wallach, J., Brandt, S. D., & Meyer, M. R. (2026). Metabolic fate and detectability of three novel fluoroprolintane psychostimulants: in vitro and in vivo characterization by hyphenated mass spectrometry. Archives of Toxicology. https://doi.org/10.1007/s00204-026-04462-4

Vancouver

Wagmann L, Herter A, Dybek MB, Adejare A, Wallach J, Brandt SD, et al. Metabolic fate and detectability of three novel fluoroprolintane psychostimulants: in vitro and in vivo characterization by hyphenated mass spectrometry. Archives of Toxicology. 2026. doi:10.1007/s00204-026-04462-4

BibTeX
@article{Wagmann2026,
  author = {Wagmann, Lea and Herter, Anica and Dybek, Michael B and Adejare, Adeboye and Wallach, Jason and Brandt, Simon D and Meyer, Markus R},
  title = {Metabolic fate and detectability of three novel fluoroprolintane psychostimulants: in vitro and in vivo characterization by hyphenated mass spectrometry},
  journal = {Archives of Toxicology},
  year = {2026},
  doi = {10.1007/s00204-026-04462-4}
}
Kostenlos starten →